Anthony Thomas Stavros MD, Presenter: Clinical Advisory Board,SuperSonic Imagine Clinical Advisory Board, Devicor Medical Products, Inc Clinical Advisory Board, SonoCiné, Inc Clinical Advisory Board, General Electric Company Clinical Research, General Electric Company Clinical Research, The Medipattern Corporation Clinical Research, SuperSonic Imagine Shareholder, U-Systems, Inc

1) How the anatomy of a lymph node affects its sonographic appearance. 2) How metastases alter the sonographic appearance of a lymph node. 3) Several methods of distinguishing whether an abnormal node is more likely metastatic or a benign reactive lymph node. 4) The landmarks that define the axillary lymph node levels, how to assess axillary lymph node levels, and breast cancer metastases spread from level to level in most cases. 5) How to assess a lymph node for peri-nodal invasion and how to perform a biopsy to prove its presence. 6) The various methods of performing biopsy of axillary lymph nodes and how ultrasound guided biopsy of axillary lymph nodes affect management of the breast cancer patient. 7) How ultrasound contrast agents could help assess axillary nodes.

http://media.rsna.org/media/abstract/2011/11000675/pfev516_11000675_Stavros_RC715B.pdf

Stavros, A, US Evaluation of Lymph Nodes.  Radiological Society of North America 2011 Scientific Assembly and Annual Meeting, November 26 - December 2, 2011 ,Chicago IL. http://archive.rsna.org/2011/11000675.html